Sibannac, Inc. (SNNC) — SEC Financial Statements & Analysis

Sibannac, Inc. (SNNC) is a pharmaceutical preparations company, incorporated in NV. Sibannac, Inc. trades on OTC as: SNNC. Sibannac, Inc. (SNNC)'s most recent SEC filing is a Form 10-Q for the period ended 2017-02-28, filed with the SEC on 2017-12-11. Based on that filing, Sibannac, Inc. carries a market cap of $3.86M, a P/E ratio of -14.62x, a P/B ratio of -9.73x, a P/S ratio of -18.07x, an enterprise value of $4.17M, and an EV/EBITDA multiple of -39.64x. On profitability, it posts a gross margin of 29.22%, an operating margin of 50.05%, a net margin of 123.57%, a Return on Equity (ROE) of 99.81%, a Return on Assets (ROA) of -71.77%, and a Return on Invested Capital (ROIC) of -134.67%. Per share, it reports EPS of $-0.02, free cash flow per share of $-0.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -183.88% year-over-year, net income growth of -89.62% year-over-year, and EPS growth of -89.62% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-396.13K, a debt-to-equity ratio of -1.66x, a debt ratio of 2.51, an interest coverage ratio of -1.76x, free cash flow of $-88.81K (TTM), and net debt of $316.90K. Figures sourced from SEC EDGAR.

Market Cap

$3.86M

P/E TTM

-14.62x

EPS TTM

$-0.02

P/B TTM

-9.73x

ROE TTM

99.81%

ROA TTM

-71.77%

Debt To Equity

-1.66x

Free Cash Flow TTM

$-88.81K

Net Revenue TTM Growth 1Y

-183.88%

Data as of 2017-02-28 · Source: SEC EDGAR